The AD brain shows impaired insulin signaling which results in the excessive activation of glycogen synthase kinase-3β (GSK-3 β) and reduced expression of glucose transporter-1 (GLUT-1) and 3 (GLUT-3) proteins [62]. Here, INS is linked to Alzheimer disease.